Journal of Clinical Endocrinology & Metabolism (2010) 3
Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL, Antonoff MB
It must be distinguished between a limited EP damage with relatively stable fragments, closed fracture lines or small defects, which result in no or a limited loss of nucleus tissue (injury type B2), from large defect with a virtual complete loss of NP tissue into the vertebral bone (type B3)
2013;5(Suppl 5):S479
Its purification is a very insidious process that elevates the cost, and this fact in combination to the limited applicability that has been linked to date, elevates the price of the treatment
They deserve to know the risks." ECRI and ISMP recommend that patients consult a licensed clinician before considering any peptide therapy, use only FDA-approved products, and purchase exclusively from regulated pharmacy sources